SCNX · Scienture Holdings, Inc.
$0.39
0.00 (-1.24%)
At close · Aug 31
Going-concern doubt
— cleared Aug 13, 2026
The latest filing states the doubt was alleviated.
“While these factors initially indicated substantial doubt about the ability of the Company to continue as a going concern, management believes that its existing cash on hand, revenues from the commercialization of ARBLI™ (SCN-102) and REZENOPY™ (SCN-110) and its planned financing activities alleviate that doubt.”View the 10-Q filed Aug 13, 2026
Market Cap
$16.18M
Shares
41.06M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Equity Offering (ATM) Programs
| Program Established | Last Amended | Capacity | Remaining | Runs Through | Source |
|---|---|---|---|---|---|
| 2025-09-19 | — | $18,792,009 | $9,592,009 as of 2025-10-24 | — | 10-K , filed 2026-03-30 |
Key facts
CIK
1382574
CUSIP
80880X104
13F (30d)
13 filings
13 filers
Visit website
Investor relations